Many healthcare executives are applauding the list of additional drugs chosen for the Medicare Drug Price Negotiation Program, while some drug companies are opposing it.
datma's platform improves the organization and usability of your pathology data for research and monetization opportunities. Accelerate research and collaborations with ready-to-use data.
Click here to learn more about datma's pathology data management solutions.
Join us at The Healthcare Investment Conference of 2025: May 20-21 in Chicago, where investors and healthcare's most promising entrepreneurs come together to connect and collaborate. This premier event fosters dynamic exchanges and meaningful connections that drive transformative innovation in healthcare.
Super Early Bird Rate Flies Away Friday, Get Your Tickets Now!
AstraZeneca's Datroway, an antibody drug conjugate (ADC), is now FDA approved for advanced cases of breast cancer that is HR positive and HER2 negative. Datroway targets TROP2, the same cancer protein addressed by Trodelvy, a Gilead Sciences ADC also approved for breast cancer.
Here are three key trends that pharma leaders and clinical operations teams should monitor this year, along with a checklist of strategic priorities to stay ahead.
Healthcare providers and vendors are learning the hard way that hackers are relentless and resourceful, constantly adjusting tactics and tools and using new technology, including AI, to launch more sophisticated attacks.
While advancements in diagnostics are promising, the need remains for healthcare professionals to take the lead on proactive conversations with patients and their loved ones about the early signs and symptoms of Alzheimer's disease.
It's tragic that it takes a shooter, aggravated by his back pain and frustrated with the healthcare system, to spark a necessary conversation about healthcare.
Post Comment
No comments